Skip to content
Case report

Localised cutaneous leishmaniasis in an immunosuppressed host: the role for adjuvant photodynamic therapy after incomplete amphotericin B response.

Sep 2026 · BMJ Case Reports · Vol 19 9 · 0 citations · 13 references
Medicine

TL;DR

An immunocompromised man in his 70s with a 15-year verrucous plaque on the right hallux initially suspected as squamous cell carcinoma is described and it is suggested that MAL-PDT may be a useful adjuvant to amphotericin B in complex CL caused by the L. donovani complex.

Abstract

Cutaneous leishmaniasis (CL) caused by the Leishmania donovani complex is uncommon in Europe and can masquerade as malignancy. We describe an immunocompromised man in his 70s with a 15-year verrucous plaque on the right hallux initially suspected as squamous cell carcinoma. Histology revealed macrophages packed with amastigotes; PCR confirmed L. donovani complex infection and serology was strongly positive. Staging excluded mucosal and visceral disease. Systemic liposomal amphotericin B achieved partial regression. Because of persistent hyperkeratosis and the acral site, adjuvant methyl-aminolevulinate photodynamic therapy (MAL-PDT) was added and was well tolerated. One month after the final session, the lesion showed near-complete re-epithelialisation with functional recovery. This case underscores the importance of early biopsy in atypical CL and suggests that MAL-PDT may be a useful adjuvant to amphotericin B in complex CL caused by the L. donovani complex.

View source

Similar papers

Open access Oct 2026

Gastric leishmaniasis in an immunocompromised patient: a case report

Leishmaniasis is a tropical infection that usually presents as a cutaneous, mucocutaneous, or visceral disease. The most common organs involved in visceral leishmaniasis are the liver, spleen, and bone marrow; involvement of the stomach is rare, with only a few cases reported to date. We present a 45-y...

A. ur Rehman, Alexander Banerjee, Bennett Christie-Nguyen et al. · 0 citations
Case report Open access Sep 2026

Reactivation of Cutaneous Leishmaniasis in a Rheumatoid Arthritis Patient Undergoing Tocilizumab Treatment

ABSTRACT. Cutaneous leishmaniasis is a neglected vector-borne disease caused by Leishmania spp., with viable parasites potentially persisting after clinical cure. Immunosuppressive therapies may favor reactivation of latent infection. The case of a 62-year-old Brazilian woman with a 25-year history of rheumatoid arthri...

Regina Maia de Souza, F. Tuon, A. Nicodemo et al. · 1 citation
Case report Open access Sep 2026

Bleomycin-based electrochemotherapy for recurrent oral CD8-positive epitheliotropic T-cell lymphoma in a dog with durable local control and necrotic regional lymph node changes: a case report

Background Oral epitheliotropic T-cell lymphoma (ETCL) is an uncommon form of canine cutaneous lymphoma involving the oral mucosa and mucocutaneous junctions. Information regarding optimal treatment strategies and prognosis is limited. Electrochemotherapy (ECT) has demonstrated efficacy against various cutaneous and su...

Makoto Akiyoshi, M. Hisasue · 0 citations
Review Oct 2026

Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.

INTRODUCTION Leishmaniasis encompass a heterogeneous spectrum of neglected tropical diseases, with clinical course and treatment outcomes strongly influenced by Leishmania species and geographic setting. Despite recent advances, their pharmacological management remains challenging. AREAS COVERED This review examines...

R. N. Sampaio, João Vitor Matachon Viana, Fellipe Magela de Araújo et al. · 0 citations
Open access Sep 2026

14 | CUTANEOUS LEISHMANIASIS MIMICKING B-CELL PSEUDOLYMPHOMA: A DIAGNOSTIC CHALLENGE IN AN ENDEMIC MEDITERRANEAN AREA

Cutaneous leishmaniasis is a zoonotic disease endemic in several areas of the Mediterranean basin, including Liguria, characterized by heterogeneous clinical and histological features that can complicate diagnosis. We report the case of a male patient with a history of frequent exposure to woodland areas, presenting wi...

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica · 0 citations
Review Open access Sep 2026

Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.

Systemic treatment options for CL show variable efficacy, and comparative evidence remains insufficient to support therapy recommendations, despite the promising cure rates for miltefosine and L-AmB.

Maximilian Egg, D. Wienand, L. Harpain et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.